Results of the INSEMA trial indicated that it’s safe to omit axillary sentinel lymph node biopsy in patients with clinically ...
Patients with early breast cancer who skipped axillary lymph node dissection (ALND) lived just as long as those who underwent ...
Omission of surgical axillary staging is noninferior to sentinel-lymph-node biopsy for patients with clinically node-negative ...
Omitting axillary SLNB does not impact outcomes in patients with early invasive breast cancer undergoing breast-conserving surgery, data suggest.